.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cipla
Daiichi Sankyo
McKinsey
Fish and Richardson
Accenture
Deloitte
Colorcon
Harvard Business School
Express Scripts

Generated: June 25, 2017

DrugPatentWatch Database Preview

Zolmitriptan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for zolmitriptan and what is the scope of zolmitriptan freedom to operate?

Zolmitriptan
is the generic ingredient in three branded drugs marketed by Aurobindo Pharma Ltd, Astrazeneca, Alembic Pharms Ltd, Macleods Pharms Ltd, Ajanta Pharma Ltd, Jubilant Generics, Glenmark Generics, Teva Pharms Usa, Pld Acquisitions Llc, IPR, Apotex Inc, Sun Pharma Global, Invagen Pharms, Mylan Pharms Inc, and Zydus Pharms Usa Inc, and is included in twenty-one NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for zolmitriptan. Nineteen suppliers are listed for this compound.

Summary for Generic Name: zolmitriptan

Tradenames:3
Patents:3
Applicants:15
NDAs:21
Drug Master File Entries: see list20
Suppliers / Packagers: see list19
Bulk Api Vendors: see list54
Clinical Trials: see list14
Patent Applications: see list4,406
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:zolmitriptan at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-004Sep 30, 2003RXYesYes► Subscribe► Subscribe
Jubilant Generics
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL202279-002Nov 20, 2014ABRXNoNo► Subscribe► Subscribe
Jubilant Generics
ZOLMITRIPTAN
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL202956-002Sep 17, 2015ABRXNoNo► Subscribe► Subscribe
Pld Acquisitions Llc
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL207867-001Feb 27, 2017ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL201779-001May 14, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zolmitriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 19975,466,699*PED► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 19975,863,935*PED► Subscribe
Astrazeneca
ZOMIG-ZMT
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL021231-001Feb 13, 20015,466,699*PED► Subscribe
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-004Sep 30, 20035,466,699*PED► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-002Nov 25, 19975,863,935*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Farmers Insurance
Mallinckrodt
US Department of Justice
Federal Trade Commission
Argus Health
Merck
Teva
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot